Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Healy, D.
1991.
What do 5HT re‐uptake inhibitors do in obsessive‐compulsive disorders?.
Human Psychopharmacology: Clinical and Experimental,
Vol. 6,
Issue. 4,
p.
325.
Gentil, Valentim
Lotufo-Neto, Francisco
Andrade, Laura
Cordás, Táki
Bernik, Márcio
Ramos, Renato
Maciel, Lucia
Miyakawa, Ernesto
and
Gorenstein, Clarice
1993.
Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine.
Journal of Psychopharmacology,
Vol. 7,
Issue. 4,
p.
316.
Healy, David
1993.
Psychopharmacology and the Ethics of Resource Allocation.
British Journal of Psychiatry,
Vol. 162,
Issue. 1,
p.
23.
Freeman, Hugh
1993.
Moclobemide.
The Lancet,
Vol. 342,
Issue. 8886-8887,
p.
1528.
Contreras, Carlos M.
Estrada, Guillermo Sanchez
Hernandez, Miguel Molina
and
Marvan, Ma.Luisa
1994.
Electroconvulsive shock decreases excitatory responses to serotonin in the caudate nucleus of the rat.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 18,
Issue. 1,
p.
193.
Mitchell, Kerry E.
Popkin, Michael K.
Trick, William
and
Vercellotti, Gregory
1994.
Psychiatric Complications Associated With Ondansetron.
Psychosomatics,
Vol. 35,
Issue. 2,
p.
161.
Contreras, Carlos M.
Beltrán, Dolores
Saavedra, Margarita
and
Molina-Hernández, Miguel
1995.
The combination of several antidepressants is not synergistic on the firing of lateral septal neurons in the rat.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 19,
Issue. 7,
p.
1157.
Healy, D.
and
Waterhouse, J.M.
1995.
The circadian system and the therapeutics of the affective disorders.
Pharmacology & Therapeutics,
Vol. 65,
Issue. 2,
p.
241.
Dubovsky, Steven L.
and
Thomas, Marshall
1995.
Beyond specificity: Effects of serotonin and serotonergic treatments on psychobiological dysfunction.
Journal of Psychosomatic Research,
Vol. 39,
Issue. 4,
p.
429.
Zacharko, Robert M.
Koszycki, Diana
Mendella, Paul D.
and
Bradwejn, Jacques
1995.
Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization.
Progress in Neurobiology,
Vol. 47,
Issue. 4-5,
p.
371.
Salter, M.
Hazelwood, R.
Pogson, C.I.
Iyer, R.
Madge, D.J.
Jones, H.T.
Cooper, B.R.
Cox, R.F.
Wang, C.M.
and
Wiard, R.P.
1995.
The Effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat.
Neuropharmacology,
Vol. 34,
Issue. 2,
p.
217.
Salter, Mark
1996.
Selective Inhibitors of Tryptophan 2,3‐dioxygenase and Combined Inhibitors of Tryptophan 2,3‐dioxygenase and 5‐HT Reuptake as Novel Serotonergic Antidepressants.
CNS Drug Reviews,
Vol. 2,
Issue. 1,
p.
127.
Ellard, John
1997.
Tests in Psychiatry.
Australian & New Zealand Journal of Psychiatry,
Vol. 31,
Issue. 6,
p.
808.
van den Burg, Willem
1998.
De (in)effectiviteit van psychofarmaca.
Dth,
Vol. 18,
Issue. 1,
p.
1.
HEALY, DAVID
1999.
The Three Faces of the Antidepressants:.
The Journal of Nervous & Mental Disease,
Vol. 187,
Issue. 3,
p.
174.
Healy, David
2000.
Some continuities and discontinuities in the pharmacotherapy of nervous conditions before and after chlorpromazine and imipramine.
History of Psychiatry,
Vol. 11,
Issue. 44,
p.
393.
Healy, David
2004.
Shaping the Intimate:.
Social Studies of Science,
Vol. 34,
Issue. 2,
p.
219.
Rees, Dai
and
Rose, Steven
2004.
The New Brain Sciences.
Petryna, Adriana
2006.
Global Pharmaceuticals.
p.
33.
Applbaum, Kalman
2006.
Global Pharmaceuticals.
p.
85.
eLetters
No eLetters have been published for this article.